Axsome Therapeutics, Inc. Annual Depreciation in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Axsome Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2015 to 2023.
  • Axsome Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $132K, a 46.7% increase year-over-year.
  • Axsome Therapeutics, Inc. annual Depreciation for 2023 was $459K, a 74.5% increase from 2022.
  • Axsome Therapeutics, Inc. annual Depreciation for 2022 was $263K, a 246% increase from 2021.
  • Axsome Therapeutics, Inc. annual Depreciation for 2021 was $76K, a 218% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $459K +$196K +74.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-23
2022 $263K +$187K +246% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-23
2021 $76K +$52.1K +218% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-23
2020 $23.9K -$13.5K -36.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $37.3K -$11.6K -23.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $48.9K +$6.38K +15% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $42.6K +$22.1K +108% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $20.5K +$16.9K +478% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 $3.54K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.